SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000903423-13-000564
Filing Date
2013-10-29
Accepted
2013-10-29 17:37:35
Documents
1
Period of Report
2013-10-29

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT glaxo.html 4  
1 OWNERSHIP DOCUMENT glaxo.xml 4 4378
  Complete submission text file 0000903423-13-000564.txt   6021
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Issuer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 980 GREAT WEST ROAD BRENTFORD MIDDLESEX X0 TW8 9GS
Business Address 980 GREAT WEST ROAD BRENTFORD MIDDLESEX X0 TW8 9GS 011442080475000
GLAXOSMITHKLINE PLC (Reporting) CIK: 0001131399 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-30319 | Film No.: 131177287
SIC: 2834 Pharmaceutical Preparations